DPA-ESDIP-JSDP Task Force for Worldwide Adoption of Digital Pathology
- PMID: 35070480
- PMCID: PMC8721866
- DOI: 10.4103/jpi.jpi_65_21
DPA-ESDIP-JSDP Task Force for Worldwide Adoption of Digital Pathology
Conflict of interest statement
The authors are active members of the societies herein presented as part of the task force (AP, LP, MMB, and LH from DPA; CE, NZ, and FF from ESDIP; and AB and JF from JSDP). Liron Pantanowitz consults for Hamamatsu and is on the medical advisory board for Ibex. Marilyn M. Bui is a scientific advisory board member of Aiforia, ContextVision, and Visiopharm.
Figures


References
-
- Griffin J, Treanor D. Digital pathology in clinical use: Where are we now and what is holding us back? Histopathology. 2017;70:134–45. - PubMed
-
- Hanna MG, Reuter VE, Hameed MR, Tan LK, Chiang S, Sigel C, et al. Whole slide imaging equivalency and efficiency study: Experience at a large academic center. Mod Pathol. 2019;32:916–28. - PubMed
-
- Araújo ALD, Arboleda LPA, Palmier NR, Fonsêca JM, de Pauli Paglioni M, Gomes-Silva W, et al. The performance of digital microscopy for primary diagnosis in human pathology: A systematic review. Virchows Arch. 2019;474:269–87. - PubMed
Publication types
LinkOut - more resources
Full Text Sources